Rockwell Medical IN (RMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,614 | 26,697 | 37,400 | 11,795 | 14,421 |
| Marketable Securities | 10,702 | 13,258 | 11,456 | 14,250 | 14,576 |
| Receivables | 4,129 | 3,565 | 4,587 | 4,203 | 5,123 |
| Inventories | 3,877 | 4,557 | 4,293 | 3,647 | 3,584 |
| TOTAL | $77,943 | $51,536 | $59,494 | $36,874 | $40,565 |
| Non-Current Assets | |||||
| PPE Net | 2,785 | 2,307 | 2,430 | 2,433 | 2,506 |
| Intangibles | 921 | 921 | 921 | 921 | 921 |
| Other Non-Current Assets | 3,587 | 3,822 | 3,981 | 4,089 | 4,096 |
| TOTAL | $7,293 | $7,049 | $7,332 | $7,443 | $7,523 |
| Total Assets | $85,236 | $58,585 | $66,826 | $44,317 | $48,087 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,190 | 3,313 | 3,371 | 3,885 | 4,609 |
| Accrued Expenses | 4,968 | 4,437 | 6,160 | 4,518 | 3,916 |
| Other current liabilities | 215 | 228 | 295 | 244 | 148 |
| TOTAL | $12,708 | $11,495 | $13,357 | $12,374 | $12,394 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,856 | 20,764 | 20,684 | N/A | N/A |
| Deferred Revenues | 2,180 | 2,175 | 2,179 | 2,234 | 2,239 |
| Other Non-Current Liabilities | 1,039 | 1,204 | 1,560 | 1,781 | 1,589 |
| TOTAL | $30,453 | $30,878 | $31,694 | $11,623 | $11,990 |
| Total Liabilities | $43,161 | $42,373 | $45,052 | $23,997 | $24,385 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,506 | 6,390 | 6,278 | 6,277 | 5,814 |
| Common Shares | 9 | 7 | 7 | 7 | 6 |
| Retained earnings | -328,743 | -321,393 | -314,500 | -306,516 | -299,214 |
| Other shareholders' equity | 49 | 46 | 51 | 52 | 73 |
| TOTAL | $42,075 | $16,212 | $21,774 | $20,320 | $23,703 |
| Total Liabilities And Equity | $85,236 | $58,585 | $66,826 | $44,317 | $48,087 |